Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Economic data collection during efficacy trials will be discussed at HHS workshop.

Executive Summary

ECONOMIC DATA COLLECTION IN CONJUNCTION WITH EFFICACY TRIALS TO BE DISCUSSED at the Department of Health & Human Services cost-effectiveness workshop scheduled for Nov. 25-26 at the National Institutes of Health campus in Bethesda, Md. The workshop is organized around the Panel on Cost-Effectiveness in Health and Medicine report released earlier this year ("The Pink Sheet" Aug. 5, T&G-16). The report states that a "rigorously designed clinical trial" may be necessary for a cost-effectiveness analysis of "a pharmaceutical agent with the potential to create undesired side effects and for which small statistical biases in study data can lead to misleading results."
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS029171

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel